Management of Persistent Hypertension After Starting ARB Therapy
Introduction to Management
- The American Heart Association recommends a stepwise approach to manage persistent hypertension after starting ARB therapy, including optimizing the ARB dose, adding a calcium channel blocker, followed by a thiazide-like diuretic, and finally adding spironolactone as a fourth agent if needed 1, 2
Initial Assessment and Optimization
- Verify proper blood pressure measurement technique using a validated device with appropriate cuff size, and confirm elevated readings with home or ambulatory blood pressure monitoring 1
- Check medication adherence, as this is a common cause of inadequate blood pressure control 3
Stepwise Medication Adjustment
- Increase ARB to maximum tolerated dose before adding additional agents, and consider once-daily dosing and single-pill combinations to improve adherence 1, 2
- For non-Black patients, add a dihydropyridine calcium channel blocker (DHP-CCB) as a second agent 2, 3
- For Black patients, add either a DHP-CCB or a thiazide/thiazide-like diuretic as a second agent 1, 4
- Add a thiazide/thiazide-like diuretic as a third agent if not already included 2, 3
- Add spironolactone as the preferred fourth-line agent for resistant hypertension, or alternatives such as amiloride 3, clonidine 3, or beta-blocker 2, 3
Target Blood Pressure and Monitoring
- Target blood pressure should be <130/80 mmHg for most patients, but individualize for elderly patients based on frailty 3, 5
- Aim to achieve target blood pressure within 3 months of treatment initiation 3
Referral to Specialist
- If blood pressure remains uncontrolled despite adherence to a four-drug regimen including a diuretic, refer to a provider with hypertension expertise 3